Literature DB >> 24657010

Prognostic significance of failure of the initial antiepileptic drug in children with benign childhood epilepsy with centrotemporal spikes.

Faruk Incecik1, Sakir Altunbasak2, Ozlem M Herguner2, Gulen Mert2, Duygu Sahan2.   

Abstract

BACKGROUND: Benign epilepsy with centrotemporal spikes is the most common partial epilepsy syndrome in children. The long-term prognosis for children with BECTS is believed to be generally excellent with seizures usually responding well to AEDs. The goal of the present study was to determine the risk factors associated with a poor prognosis.
METHODS: Eighty-four children with BECTS were retrospectively analyzed. Fifty-four (64.3%) were boys and 30 (35.7%) were girls with the mean age at seizure onset 7.1 ± 2.01 years (range: 3-12 years).
RESULTS: Of the 84 patients, 72 (85.7%) were treated successfully with the first AED (Group A), and 12 (14.3%) failed to responded to the initial AED treatment (Group B [poor prognosis]). Univariate analyses suggested that younger age of seizure onset, presence of generalized seizures, and frequent seizures (>3 prior to the initial treatment) were associated with failure to control seizures with the initial AED. Multivariate analysis suggested that younger age of seizure onset was the independent risk factor predicting a poor response to initial AED treatment.
CONCLUSION: About 14% of our cohort of children with BECTS continued to have seizures following the initial AED treatment. Further prospective studies are warranted to determine how well prognosis can be predicted by age of seizure onset, type of seizures, and frequency of pre-existing seizures in children with BECTS.
Copyright © 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Benign epilepsy with centrotemporal spikes; Children; Failure risk factors; First antiepileptic drug

Mesh:

Substances:

Year:  2014        PMID: 24657010     DOI: 10.1016/j.braindev.2014.02.008

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  3 in total

1.  Nightly oral administration of topiramate for benign childhood epilepsy with centrotemporal spikes.

Authors:  Chunrong Liu; Mei Song; Jiwen Wang
Journal:  Childs Nerv Syst       Date:  2016-03-16       Impact factor: 1.475

2.  Benign epilepsy with centrotemporal spikes: Relationship between type of seizures and response to medication in a Greek population.

Authors:  Anastasia Gkampeta; Liana Fidani; Dimitrios Zafeiriou; Evangelos Pavlou
Journal:  J Neurosci Rural Pract       Date:  2015 Oct-Dec

3.  Factors Predicting Poor Response to Initial Therapy in Benign Childhood Epilepsy with Centrotemporal Spikes (BCECTS).

Authors:  Yoon Kyoung Park; So-Hee Eun; Baik-Lin Eun; Jung Hye Byeon
Journal:  J Epilepsy Res       Date:  2015-12-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.